021-51111890
购物车（）
sales@molnova.cn
Suritozole
CAS No. 110623-33-1
Suritozole ( MDL-26479 )
产品货号. M22215 CAS No. 110623-33-1
Suritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptorSuritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥1604 | 有现货 |
|
| 5MG | ￥2406 | 有现货 |
|
| 10MG | ￥3669 | 有现货 |
|
| 25MG | ￥6051 | 有现货 |
|
| 50MG | ￥8505 | 有现货 |
|
| 100MG | ￥11502 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Suritozole
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Suritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptorSuritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat.
-
产品描述Suritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptorSuritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat.
-
同义词MDL-26479
-
通路Others
-
靶点Other Targets
-
受体GABAA
-
研究领域——
-
适应症——
化学信息
-
CAS Number110623-33-1
-
分子量223.27
-
分子式C10H10FN3S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESS=C1N(C)N=C(C2=CC=CC(F)=C2)N1C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.O'Dell D M , Hamm R J . Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury[J]. Journal of Neurosurgery, 1995, 83(5):878-83.
产品手册
关联产品
-
Guvacine
Guvacine can enhance the inhibition of spinal neurones by GABA.
-
3-O-Methylducheside ...
3-O-Methylducheside A is a natural product for research related to life sciences.
-
Wulignan A1
Wulignan A1 exhibits activity against leukemia P-388 in vitro; it also may have anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities.
